DETECTION OF SARS-CoV-2 ANTIBODIES
PerkinElmer Assays for Detection of SARS-CoV-2 Antibodies
Immunoassays detect antibodies to SARS-CoV-2 instead of identifying the live virus. According to the FDA, antibodies to SARS-CoV-2 develop approximately one to three weeks after infection and persist for a long period of time. Therefore, antibody determination is not a suitable measure to identify people who are infectious. They are not suitable to determine the difference between a sample from a person with an active infection who can spread the disease and a sample from a person who has recovered from the infection. However, they can be quite valuable as a tool for disease surveillance and investigational purposes.
PerkinElmer offers a number of different types of SARS-CoV-2 immunoassays with varied samples types, throughputs, run times, and targets. The table below will help you decide which solution best fits your needs.
Enzyme-linked immunosorbent assay
|Run Time||15 minutes
| 20 minutes
|< 2 hours
|Automated ~ 1,152||Manual – Variable||Automated ~ 5,000||Automated ~ 2,100
Manual – Variable
|Ab target||IgG (S1)||IgA+IgM+IgG (S1)||IgG (S1)||IgA (S1)
IgG (S1, NCP)
|Sample type||Serum, Plasma, Whole Blood||Serum, Plasma, Fingerpick Whole Blood||Serum, Dried Blood Spot||Serum, Dried Blood Spot for IgG|
Products may not be licensed in accordance with the laws in all countries, such as the United States and Canada. Please check with your local representative for availability.
* For emergency use authorization only. Products may not be licensed in accordance with the laws in all countries. Please check with your local representative for availability.